Esperion Therapeutics (ESPR)
(Delayed Data from NSDQ)
$2.34 USD
0.00 (0.00%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $2.37 +0.03 (1.28%) 4:48 PM ET
2-Buy of 5 2
C Value A Growth C Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/06/2024
Time: BMO |
6/2024 | $-0.14 | 64.29% |
Earnings Summary
For their last quarter, Esperion Therapeutics (ESPR) reported earnings of $0.34 per share, beating the Zacks Consensus Estimate of $-0.08 per share. This reflects a positive earnings surprise of 525.00%. Look out for ESPR's next earnings release on August 06, 2024. For the next earning release, we expect the company to report earnings of -$0.14 per share, reflecting a year-over-year increase of 69.57%.
Earnings History
Price & Consensus
Zacks News for ESPR
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
ESPR: What are Zacks experts saying now?
Zacks Private Portfolio Services